Point72 (Difc) LTD Prothena Corp Public LTD CO Transaction History
Point72 (Difc) LTD
- $3.17 Trillion
- Q1 2024
A detailed history of Point72 (Difc) LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Point72 (Difc) LTD holds 8,918 shares of PRTA stock, worth $178,984. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,918Holding current value
$178,984% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
45.4MCall Options Held
119KPut Options Held
144K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$232 Million8.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.2MShares$84.3 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.75MShares$75.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.72MShares$74.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$69.7 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $942M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...